“Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women.”, J Infect Dis, vol. 204, no. 6, pp. 854-63, 2011.
, “Randomized, placebo-controlled trial to assess the safety and immunogenicity of an adenovirus type 35-based circumsporozoite malaria vaccine in healthy adults.”, Hum Vaccin Immunother, vol. 9, no. 12, pp. 2548-57, 2013.
, “Clinical and immune responses to inactivated influenza A(H1N1)pdm09 vaccine in children.”, Pediatr Infect Dis J, vol. 33, no. 8, pp. 865-71, 2014.
, “Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial.”, JAMA, vol. 312, no. 14, pp. 1420-8, 2014.
, “Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections.”, N Engl J Med, vol. 372, no. 12, pp. 1093-103, 2015.
, “Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects.”, Vaccine, vol. 33, no. 39, pp. 5225-34, 2015.
, “Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial.”, JAMA, vol. 314, no. 3, pp. 237-46, 2015.
, “Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine.”, Vaccine, vol. 34, no. 4, pp. 547-554, 2016.
, “Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination.”, J Infect Dis, vol. 214, no. 7, pp. 1020-9, 2016.
, “Cell-Based Systems Biology Analysis of Human AS03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled Trial.”, PLoS One, vol. 12, no. 1, p. e0167488, 2017.
, “A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses.”, N Engl J Med, vol. 376, no. 26, pp. 2545-2555, 2017.
, “Proteomics show antigen presentation processes in human immune cells after AS03-H5N1 vaccination.”, Proteomics, vol. 17, no. 12, 2017.
, “AS03-Adjuvanted H5N1 Avian Influenza Vaccine Modulates Early Innate Immune Signatures in Human Peripheral Blood Mononuclear Cells.”, J Infect Dis, vol. 219, no. 11, pp. 1786-1798, 2019.
, “Mupirocin for Decolonization of Infants in Neonatal Intensive Care Units.”, Pediatrics, vol. 143, no. 1, 2019.
, “Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents.”, Vaccine, vol. 37, no. 36, pp. 5161-5170, 2019.
, “Effect of Concomitant Antibiotic and Vaccine Administration on Serologic Responses to Rotavirus Vaccine.”, J Pediatric Infect Dis Soc, vol. 9, no. 4, pp. 479-482, 2020.
, “Remdesivir for the Treatment of Covid-19 - Preliminary Report.”, N Engl J Med, 2020.
, “Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical Trial”, JAMA Pediatr, vol. 176, no. 3, pp. 253-261, 2022.
,